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Neuropeptides are small signaling molecules found throughout the nervous 
system that influence animal behavior. Using the American lobster, Homarus 
americanus, as a model system, this research focused on an allatostatin type-C (AST-C) 
peptide, pQIRYHQCYFNPISCF (disulfide bond between underlined cysteine residues), 
and a structurally similar crustacean peptide, SYWKQCAFNAVSCFamide. These 
neuropeptides influence cardiac muscle contraction patterns and stomatogastric nervous 
system activity in the lobster. To understand their roles, this study sought to develop a 
method to quantify peptides in the pericardial organ (PO) and other crustacean tissues. 
Overall analysis involved microdissection to isolate tissues, tissue extraction, extract 
purification and concentration, and analysis by chip-based nano-electrospray ionization-
liquid chromatography-mass spectrometry (nanoESI-LC-MS). In the present study, 
pQIRYHQCYFNPISCF was identified in the PO. To quantify target peptides, internal 
standards were tested as recovery and calibration references. However, experiments with 
pQIRYHQCYFNPISCF and other peptides showed evidence of adsorptive losses during 
sample preparation and analysis, with improvements in recovery resulting from the use of 
isopropanol-prewashed polypropylene vials. Preliminary results also suggested that 
introducing polyethylene glycol (PEG) in solution reduced adsorptive losses for 
hydrophobic peptides, but may have compromised hydrophilic peptide detection. Future 
directions include characterizing other sources of analyte loss and developing techniques 
to recover these signals. Since both target peptides as detected in the lobster are post-
translationally modified, other directions include identifying modified and unmodified 
forms of these peptides in H. americanus. Ultimately, quantifying AST-C peptides and 
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identifying their modified and unmodified forms will help explain how neuropeptides 





1.1 Context of study 
Hundreds of signaling molecules called neuropeptides are responsible for 
influencing behavior in humans and other animals. Neuropeptides are short α-amino acid 
chains found throughout the nervous system. They originate from large precursor 
proteins, or prepro-hormones, that are transcribed and translated from genomic genetic 
material. These precursor proteins are post-translationally cleaved into several smaller 
peptides by enzymatic processes. Like all amino acid chains, neuropeptides consist of a 
series of amino acid residues linked by amide bonds (Fig. 1). The side of an unmodified 
amino acid chain terminating with an amine group is called the N-terminus; the end with 
a carboxylic acid group is the C-terminus. Structures and masses of the twenty amino 
acids are presented in Table 1.  
 
Fig. 1. Peptide structure. Amino acids are linked by amide bonds, with 
the N-terminus given by the amine group and the C-terminus given by the 
carboxylic acid. Amino acid identity given by unique side chain (R 
group). 
Active neuropeptides interact with membrane receptors to control behavior. Some 
neuropeptides must be post-translationally modified by enzymatic processes in order to 
become bioactive. Post-translational modifications may occur at the N- or C-terminus, 
Amide bond 
N-terminus 




such as a C-terminal amidation (Fig. 2A). Other modifications may be internal, such as 
the linking of two cysteine residues by a disulfide bond (Fig. 2B). Some neuropeptides 
are active without being post-translationally modified or being minimally modified 
(Perdew, 2007; Hou et al., 2012).  
 
Fig. 2. Examples of post-translational modifications. (A) C-terminal 
amidation via the partial cleavage of a terminal glycine to form a terminal 
amide. (B) Disulfide bond formation between two cysteine residues. Both 
conversions are mediated by enzymes in the organism. 
Current research involves investigating neuropeptide interactions and the 
mechanisms through which they regulate biological activity. Since the purpose of having 
hundreds of neuropeptides in a given system is unknown, determining the unique 
functions of a given peptide will help elucidate their functional roles within a system. 
Whereas mammals have highly complex nervous systems, crustaceans have far fewer 
neurons and neuropeptides and are appropriate model systems for neuropeptide research. 
The American lobster, Homarus americanus has been used for studies of invertebrate 





systems (Ma et al., 2009; Christie et al., 2010). In particular, after being removed from 
the animal, the stomatogastric nervous system and heart remain intact and functional. 
This is another advantage of using H. americanus as a model system and greatly 
facilitates the analysis of neuropeptide effects (DeKeyser and Li, 2006; Christie et al., 
2010).  
Within these systems, allatostatin type-C (AST-C) peptides are of particular 
interest due to their influence on cardiac muscle contraction patterns in H. americanus. 
Originally identified in insects as juvenile hormone production inhibitors in the corpora 
allata, the AST-C family is distinguished by a –PISCF sequence at the unblocked C-












Table 1. Amino acid abbreviations, residue masses, and side chain structures. Adapted 
from Luppino 2010.  
Amino Acid Abbreviation Code 
Residue Mass 
(Da) Side Chain Structure 
Alanine Ala A 71.03711  
Arginine Arg R 156.10111 
 
Asparagine Asn N 114.04293 
 
Aspartate Asp D 115.02694 
 
Cystine Cys C 103.00918  
Glutamate Glu E 129.04259 
 
Glutamine Gln Q 128.05858 
 
Glycine Gly G 57.02146  
Histidine His H 137.05891 
 
Isoleucine Ile I 113.08406 
 
Leucine Leu L 113.08406  
Lysine Lys K 128.09496  
Methionine Met M 131.04048  
Phenylalanine Phe F 147.06841 
 
Proline Pro P 97.05276 
 
Serine Ser S 87.03203  
Threonine Thr T 101.04768 
 
Tryptophan Trp W 186.07931 
 
Tyrosine Tyr Y 163.06333 
 




1.2 Neuropeptides of interest 





) was the first type-C allatostatin to be identified in a non-insect and has 
been found to be widely distributed throughout the H. americanus nervous system 
(Stemmler et al., 2010). This peptide was found in the eyestalk, where many 
neuropeptides are manufactured and stored, and in the pericardial organ (PO), a tissue 
that delivers neuropeptides to cardiac muscle (Fig. 3) (Christie et al., 2010). Visualization 
by immunohistochemistry shows that pQIRYHQCYFNPISCF in the PO localizes to the 




Fig. 3. Crustacean nervous system. (A) Whole body shown with (B) 
thoracic nervous system highlighted. This study focuses on the pericardial 
organ (PO) (dark orange), a tissue that delivers neuropeptides to cardiac 





Similar to many other neuropeptides, pQIRYHQCYFNPISCF is post-
translationally modified from its original form, QIRYHQCYFNPISCF (Fig. 5A). 
Through enzymatic processes, the N-terminal glutamine is converted to a pyroglutamate 
group and the hydrogens on the cysteine R-groups are lost to form a disulfide bridge 




 residues. The final processed peptide is 
pQIRYHQCYFNPISCF (Fig. 5B). It is unknown whether this peptide is present in the 
animal in any unprocessed forms, such as one having an unmodified N-terminus or a 




Fig. 4. Target peptide visualization in the PO. pQIRYHQCYFNPISCF 
(green) and SYWKQCAFNAVSCFamide visualization in the PO by 
immunohistochemistry (bottom) with corresponding schematic drawing (top). 
pQIRYHQCYFNPISCF localizes to the nerve projecting from thoracic 
ganglion and the neurosecretory endings. No notable quantities of 
SYWKQCAFNAVSCFamide are found in the PO; the Dickinson Lab 
concluded that the red staining was primarily nonspecific. Adapted from 
figures provided by P. Dickinson and E. Dickinson.  
ASTC-real
Neurosecretory Endings 




















Fig. 5. Target peptide post-translational modification. (A) unmodified 
QIRYHQCYFNPISCF and (B) pQIRYHQCYFNPISCF after the 





. (C) unmodified SYWKQCAFNAVSCFG and (D) 
SYWKQCAFNAVSCFamide after C-terminal amidation and the 





In addition to pQIRYHQCYFNPISCF, a structurally similar peptide has been 
identified in H. americanus as SYWKQCAFNAVSCFamide. This peptide is initially 
translated as SYWKQCAFNAVSCFG (Fig. 5C). Like pQIRYHQCYFNPISCF, it 
undergoes enzymatic post-translational modification that converts the C-terminal glycine 





residues. Its N-terminus is left unblocked and the resulting processed form is 
SYWKQCAFNAVSCFamide (Fig. 5D). Both pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide influence pyloric rhythm frequency in the stomatogastric 
nervous system and cardiac muscle contraction patterns (Dickinson et al., 2009; Ma et al., 
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2009; Christie et al., 2010). It is also unknown whether any unmodified forms, such as 
one having an unamidated C-terminus or a reduced form lacking a disulfide bond, are 
present in the animal or whether they are bioactive. 
It has been observed that cardiac muscle contractions of different lobsters of the 
same species exhibit two different responses to applications of pQIRYHQCYFNPISCF 
and SYWKQCAFNAVSCFamide. This response is unusual, as two animals of a single 
species generally respond similarly to a given treatment; however, when the semi-intact 
heart is exposed to pQIRYHQCYFNPISCF, the amplitude of cardiac muscle contractions 
increases in some lobsters and decreases in others. Cardiac muscle contraction frequency 
consistently decreases across preparations. This inter-animal variability and the structural 
similarity between pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide make 
these crustacean peptides interesting candidates for the study of neuropeptides 
(Wiwatpanit et al., 2012). Currently, post-translational modifications of 
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide have been identified (Fig. 5), 
but other modified forms of these peptides are unknown.  
1.3 Peptide characterization by liquid chromatography-mass spectrometry (LC-MS) 
and tandem mass spectrometry (MS/MS) 
In this study, we were working to develop a method to identify and quantify 
modified and unmodified forms of pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide in H. americanus eyestalk and PO tissue extracts using 
internal standards and chip-based nano-electrospray ionization-liquid chromatography-
mass spectrometry (nanoESI-LC-MS). NanoESI LC-MS is a highly sensitive technique 
that allows for the detection of femtomolar amounts of peptides in small sample volumes 
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while preserving detection accuracy, robustness, and precision (Karas et al., 2000; Yin 
and Killeen, 2007). Overall, samples may be separated by chromatography and 
subsequently identified by mass using mass spectrometry by measuring their mass-to-
charge ratio (m/z). Peptides can also be sequenced by fragmenting target analytes and 
identifying the m/z values associated with each fragment using tandem mass 
spectrometry (MS/MS).  
The first step of this technique is high performance liquid chromatography 
(HPLC), which separates liquid sample components based on properties such as their 
size, charge, and interactions with the hydrophobic stationary phase column (Ho et al., 
2003). In a conventional LC-MS instrument, the sample travels through a hydrophobic 
separation column to separate components. This column is connected to an ESI ionization 
source that nebulizes and ionizes the sample for MS analysis. However, the connections 
between the columns, capillaries, and valves involved in this process can leak and cause 
high sample loss (Yin and Killeen, 2007). To overcome such challenges posed by 
conventional LC-MS systems, an Agilent HPLC-Chip has been used for both HPLC 
sample separation and nanoelectrospray ionization (nanoESI) in this study. The chip is a 
multilayer polyimide film that eliminates leaky connectors and adapters, thereby 
maximizing sensitivity and ease of use. The liquid sample is injected and flows onto an 
enrichment column in the chip to be concentrated and washed to eliminate contaminants. 
When flow is directed from the enrichment column to the analytical column by rotation 
of a rotary valve, the hydrophobic analytical column separates the sample components, 
which travel through the column at different rates and elute at characteristic retention 
times. Lastly, a nanoESI tip is used for sample ionization before MS analysis (Yin and 
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Killeen, 2007). Liquid chromatography with MS detection yields a chromatogram of 
instrument response vs. retention time, which allows sample components to be 
distinguished based on elution time.  
For mass analysis (Fig. 6), the liquid sample must be converted into gas phase 
ions by electrospray ionization. The liquid is nebulized from the nanoelectrospray tip on 
the HPLC-Chip using an electric field to yield highly charged droplets that are driven 
electrostatically to the mass analyzer inlet. Nitrogen gas is used to dry the sample so that 
the solvent evaporates and only the analyte ions reach the mass spectrometer. Since the 
mass spectrometer identifies analytes by their mass-to-charge (m/z) ratios, very large 
molecules can be detected by this technique because ESI allows for the formation of 
multiply charged ions. For example, a protein with molecular weight of 10,000 Da that is 
charged by one, two, three, four, or five protons would be detected as having an m/z ratio 
of 10,001, 5001, 3334, 2501, or 2001 Da, respectively. This greatly widens the mass 
range of analytes that can be detected using this technique (Siuzdak, 1996).  
Mass spectrometry uses a mass analyzer and detector to determine the m/z ratio of 
the analyte ions. For the quadrupole time-of-flight (Q-TOF) mass analyzer used in this 
study, ions travel from the ionization region through eight metal rods called an octupole 
ion guide that ensures transmission of nearly all the target ions. The ions then enter the 
quadrupole mass filter, which consists of four rods that either can be used to transmit a 
wide range of ions to the TOF mass analyzer (MS mode), or can select a precursor ion for 
dissociation (MS/MS mode). In either mode, the ions are injected into the TOF mass 
analyzer, where they are accelerated to the same kinetic energy and mass analyzed by the 
differences in velocity resulting from differences in m/z. Using differences in flight times, 
11 
 
the mass analyzer determines the m/z of each ion at high resolution. Ultimately, spectra of 
abundance vs. m/z are collected at various retention times. Peak patterns in the MS 
spectrum reveal the charge state (number of added protons) for a given species and allow 
for the determination of the mass of the ion (Williamson and Bartlett, 2007); the exact 
mass measurements permit highly specific identifications based upon elemental 
compositional differences.  
 
 
In order to determine the chemical identity and amino acid sequence of 
neuropeptides, tandem mass spectrometry (MS/MS) is used to sequence target molecules. 







Fig. 6. Schematic diagrams of a mass spectrometer. (A) Block diagram 
of a mass spectrometer. Adapted from Kinter & Sherman 2000. HPLC-
chip involved in both the separation of sample components by HPLC and 
ionization by nanoESI. (B) Schematic diagram of Q-TOF mass analyzer. 
Adapted from (Vollmer et al., 2011).  
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accelerated into the hexapole collision cell (Fig. 6). Here, the accelerated ion collides 
with gas molecules (N2) and the collisions produce product ions and uncharged 
fragments. The product ions are analyzed in TOF mass analyzer to determine their m/z 
and infer their masses (Kinter and Sherman, 2000). 
To characterize pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide by 
MS and MS/MS, their measured m/z values will be compared to their expected exact 
masses and sequences. Based on the peptide sequences, their neutral exact masses are 
expected to be 1898.823 Da and 1649.712 Da, respectively. Using ESI, which allows for 
the formation of multiply charged species, all available basic sites on a peptide are 
expected to be protonated. Peptides are typically protonated at the N-terminal amine and 
at the basic residues lysine (K), arginine (R), and histidine (H) (Kinter and Sherman, 
2000). Since a pyroglutamate group is not expected to be basic enough to be protonated, 





SYWKQCAFNAVSCFamide is expected to be protonated at the N-terminus and Lys
4
 
residue. In addition to MS mass measurements, MS/MS analysis should confirm these 
amino acid sequences. Unmodified peptides will show retention time, m/z, and MS/MS 
mass spectral differences relative to the modified peptides. 
1.4 Peptide quantification by internal standard 
Internal standards have been used in previous studies to quantify peptides in 
biological tissues. Calibration using internal standards is a powerful quantification 
technique that can account for sample loss occurring throughout the tissue extraction and 
sample preparation when the internal standards are added at the beginning of the sample 
preparation process. Isotopically labeled standards are the most accurate because they 
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behave essentially identically to the target peptides. However, structurally-related 
analogue internal standards may also be used for quantification, as these are more 
accessible and economical and can be selected to mimic the behavior of the target 
peptides (Bronsema et al., 2013).  
1.5 Quantifying AST-C peptides in H. americanus 
Methods for quantifying pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide will be explored using structurally similar internal 
standards. In order to make use of an internal standard, the amount of internal standard 
that must be added to the initial sample must be determined. Ideally, the amount of 
internal standard detected will be comparable to the amount of target peptide detected. 
However, the concentrations of AST-C peptides in crustacean tissue have not yet been 
quantified and may vary from animal to animal, making it difficult to apply internal 
standard techniques to the analysis. To address this challenge, a mixture of at least three 
internal standards will be added to the tissue extraction solvent. The concentration of 
each internal standard will differ by one order of magnitude. This way, the target peptide 
signal can be compared to the internal standard signal that is closest in intensity in order 
to maximize accuracy (Fig. 7). 
To determine peptide concentrations following tissue extraction and sample 
preparation, the internal standard instrument responses will be compared to the known 
internal standard concentrations added to the extraction solvent. Using a calibration curve 
constructed from calibration data, the concentrations of pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide originally present in the tissue will be determined from the 
detected concentrations of these target peptides. Optimal internal standard concentrations 
14 
 
will be determined empirically by estimating target peptide levels and testing for standard 
concentrations that maximize signal reliability and consistency. Ideally, the target peptide 
concentration will be near the center of the internal standard concentration range.  
 
 
Fig. 7. Peptide quantification by internal standard. 
Determination of pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide concentrations based on amounts of 
various internal standards. Chromatographic peak intensity for 
target peptides may vary over a wide range and will be compared 
to the internal standard peak with most similar intensity.  
 
1.6 Project goals 
In this study, peptide extraction and detection will be optimized and techniques 
will be tested to identify and quantify pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide in H. americanus tissue. Both peptides will be analyzed in 
the eyestalk and the former will also be analyzed in the PO. To identify target peptides, 
standards will first be characterized by liquid chromatography-mass spectrometry (LC-
MS, described in more detail below). Eyestalk and PO tissue extracts will be analyzed for 
these peptides and delipidation techniques will be tested to reduce phospholipid 
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contamination. Ultimately, techniques for quantifying peptides by internal standard and 
reducing peptide signal loss will be explored.  
EXPERIMENTAL 
2.1 Instrumentation 
For chromatography and nano-electrospray ionization (nanoESI) for peptide 
standards and tissue extracts, a 1260 Chip Cube system (Agilent Technologies) and a 
ProtID-chip with a 40-nL enrichment column and a 150 mm x 75 m analytical column 
(Agilent Technologies) were used. The enrichment and analytical columns were packed 
with 300-Å, 5-m particles with C18 stationary phase. The mobile phases were 0.1% 
formic acid (FA) with 2% water in acetonitrile (ACN) and 0.1% FA in water, 300-nL/min 
flow rate; 0.01 to 1.0 L injected. The mobile phase gradient was optimized for standard 
characterization and sample analysis.  
A 6530 quadrupole time-of-flight (Q-TOF) mass analyzer (Agilent Technologies, 
Santa Clara, CA) was used for mass spectrometric analysis. Mass spectra were collected 
in positive (or negative) ion mode; the ionization voltage ranged from 1750 -1950 V, the 
fragmentor voltage was 175 V and the source temperature was held at 300 °C. Spectra 
were internally calibrated using reference compounds. Methyl stearate (C17H35CO2CH3) 
and hexakis (1H, 1H, 4H-hexafluorobutyloxy) phosphazine (HP-1221; 
C24H18O6N3P3F36), continuously infused and detected as [M+H]
+
, were used to internally 
calibrate all spectra in positive ion mode.  
2.2 Animals 
American lobsters (Homarus americanus) were purchased from Gurnet Trading 
Co. and kept in recirculating seawater tanks at 10-12 C (Brunswick, ME).  
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2.3 Chemicals and sample storage and analysis vials 
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide were synthesized by 
GenScript (Piscataway, NJ, purities 95.7% and 95.1%, respectively). An extraction 
solvent of 85% acetone (SigmaAldrich, > 99%), 13% deionized water, and 2% HCl 
(Fisherbrand; reagent grade) as a %[v/v] mixture was used for some tissue samples. For 
other samples, an extraction solvent of solvent 64% methanol (Fischer Scientific, > 99%), 
29% deionized water, and 7% acetic acid (SigmaAldrich, > 99%) as a %[v/v] mixture 
was used. Dithiothreitol (DTT) (SigmaAldrich, > 99%) was used to reduce disulfide 
bonds in peptide standards. Chloroform (Cambridge Isotope Laboratories; NMR-grade 
13







]vasopressin, and oxytocin (American Peptide Co., > 99%) were selected as internal 
standards.  
2.4 Peptide standard preparation and characterization 
To characterize pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide, 10 
µM and 5 µM standards of each peptide were prepared using a serial dilution. First, 10
-3
 
M stock solutions in water were diluted to 10 µM in plastic vials. These solutions were 
diluted to 5 µM in conical polypropylene vials for LC-MS analysis. Serial dilutions were 
also performed using low-retention plastic tubes and non-serial dilutions were prepared 
by diluting peptide standards directly into conical polypropylene vials for analysis.  
2.5 Disulfide bond reduction by dithiothreitol (DTT) 
To reduce the disulfide bond linking the cysteine residues in the target peptide, 66 
µL of 0.2 M dithiothreitol (DTT) was added to 20 µL of 100 µM 
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SYWKQCAFNAVSCFamide in a polypropylene vial. The reaction was allowed to 
proceed at room temperature for 15 min.  
2.6 Tissue extraction 
Tissues (eyestalks and POs) were removed from the lobster using microdissection 
techniques and were immediately heated at 100 °C for 5 min in 50 µL of preheated 
extraction solvent in 0.6 mL low-retention tube (rinsed 3 x 200 µL of extraction solvent). 
Both an acetone solvent (85% acetone/13% deionized water/2% hydrochloric acid) and 
methanol solvent (64% methanol/29% water/7% acetic acid) were tested. The tissue was 
homogenized either by manually compressing and grinding the sample with a 0.2-mL 
low-retention tube (outside rinsed with acetone extraction solvent) or by using a 
polypropylene pellet pestle with cordless motor (SigmaAldrich). Tissues were sonicated 
for 5 min and centrifuged for 10 min at 10.1 g. The supernatant and an additional 100 µL 
of extraction solvent were filtered through a 0.45-µm filter (rinsed 3 x 300 µL of 
extraction solvent and centrifuged for 15 s per wash at 10.1 g) and centrifuged for 1 min 
at 10.1 g. An additional 100 µL of extraction solvent was drawn through the filter twice, 
centrifuged for 60 s, and the filtrate was vacuum dried. Samples not to be immediately 
analyzed were stored at -80 °C at this step. For analysis, vacuum dried samples were 
reconstituted in 50 µL of 25% acetonitrile (ACN), sonicated 5 min, and transferred to a 
conical polypropylene vial. Samples were analyzed by LC-MS. 
2.7 Delipidation 
A delipidation approach was tested by adding 50 µL of chloroform to the 350 µL 
filtrate before vacuum drying. The mixture was pipetted several times to mix, sonicated, 
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and let sit to separate. The bottom chloroform layer was removed and the resulting 
aqueous layer was vacuum dried and analyzed by LC-MS.  
2.8 Detection limit assessment  
Both target peptide standards were added to separate 40 µL aliquots of pooled 
eyestalk extracts at concentrations of 500, 100, 50, 10 and 1 nM. Samples were replicated 
so that two equivalent samples were analyzed for one target peptide at a single 
concentration. Serial dilutions were prepared from 10
-3
 M target peptide solutions in 
water in low-retention tubes. Chromatographic peaks were integrated and plotted as a 
function of peptide concentration to evaluate signal-to-concentration linearity.  







]vasopressin, and oxytocin 
in water were prepared and characterized by chromatography and MS as described in 
Section 2.4. Mixtures of 1, 10, 100, and 1000 nM of each of these standards were then 
characterized, followed by mixtures of 100 nM of the four internal standards and the two 
target peptides. Multiple preparations of 100 and 10 nM mixtures of [Arg
8
]vasotocin and 
the two target peptides were also analyzed at an injection volume of 1.0 µL. Lastly, the 
mixtures shown in Table 2 were analyzed by chromatography to determine an internal 


















(M) oxytocin (M) 
1 None 1.00 x 10
-4
 1.00 x 10
-5
  1.00 x 10
-6
  
2 1.00 x 10
-4
 1.00 x 10
-5
  1.00 x 10
-6
  1.00 x 10
-7
  
3 1.00 x 10
-5
  1.00 x 10
-6
  1.00 x 10
-7
  1.00 x 10
-8
  
4 1.00 x 10
-6
  1.00 x 10
-7
  1.00 x 10
-8




2.10 Dilution preparation with vial prewashing 
Both polypropylene and glass vials were prewashed with water, 25% ACN, and 
isopropanol (all purchased from Fisher Scientific, LC-MS grade) to test the effectiveness 
of these solvents at preventing adsorptive losses. Each vial was washed 3 x 500 µL of 
each solvent and dried in open air overnight to ensure solvent evaporation. After these 
tests, all polypropylene vials used for analysis were prewashed by full submersion in 
isopropanol in a beaker and sonication for 5 min. The isopropanol was then discarded and 
this washing was repeated. Vials dried overnight in the beaker, which was partially 
covered in aluminum foil to prevent contamination while allowing evaporation. For 
subsequent experiments testing dilution preparation techniques, pipette tips and low-
retention tubes were prewashed by repeated isopropanol submersion, sonication, and 
drying as described.  
2.11 Dilution preparation to test signal recovery 
Solutions of seven peptides at equal concentrations were prepared from standards 
synthesized by GenScript (Piscataway, NJ, purity shown in parentheses): RTVGGFA 
(99.3%), RAAFGFA (99.4%), AST-B (> 95%), RTVFGFA (99.8%), 
AFDEIDRSGFGFA (97.8%), CLDH (95.3%), and pQIRYHQCYFNPISCF. All 10
-3
 M 
stock solutions were stored at –20°C and were fully thawed and sonicated for 5 min 
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before diluting. Samples were prepared by diluting a 10
-4
 M mixture of all peptides to be 
analyzed in isopropanol-washed low-retention tubes.  
RESULTS AND DISCUSSION 
3.1 Peptide standard characterization (oxidized and reduced forms) 
Standards of pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide and their 
reduced forms were successfully characterized by chromatography, MS, and MS/MS. 
Based on the predicted target peptide sequences, the expected masses for the singly-, 
doubly-, and triply-charged states were calculated (Table 3). For 10 µM peptide solutions 
(prepared by diluting stock solutions directly into polypropylene vials), the 
chromatograms showed intense chromatographic peaks (Fig. 8A and C) whose MS 
spectra matched the expected masses (Fig. 8B and D) for each standard. Using the 
specified mobile phase gradient, pQIRYHQCYFNPISCF eluted at 7.02 min (Fig. 8A) 
and SYWKQCAFNAVSCFamide at 6.37 min (Fig. 8C). pQIRYHQCYFNPISCF 
consistently eluted after SYWKQCAFNAVSCFamide. Since modifications to the mobile 
phase gradient changed elution patterns, peptide retention times varied between analyses. 
Nonetheless, pQIRYHQCYFNPISCF consistently eluted after 
SYWKQCAFNAVSCFamide. This was consistent with expectations because 
pQIRYHQCYFNPISCF is the larger peptide, as indicated by its higher mass. This later 
elution time also suggests that pQIRYHQCYFNPISCF is more hydrophobic, which can 
be attributed to its pyroglutamate group. Upon pyroglutamate formation by the 
cyclization of the N-terminal glutamic acid, two hydrophilic amine groups are lost 
(Schlenzig et al., 2009). This increases the hydrophobicity of pQIRYHQCYFNPISCF 
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and, along with its larger size, causes greater retention by the hydrophobic C18 analytical 
column compared with SYWKQCAFNAVSCFamide.  
Although MS analysis does not indicate specific protonation sites, probable sites 
for protonation were predicted and are shown in bold in Table 3. Basic amino acid 
residues as well as unblocked N-termini were expected to be protonated. Both peptides 





) and SYWKQCAFNAVSCFamide at the N-terminus and the 
basic Lys
4
 residue. For both target peptides, the doubly-charged ion was most abundant, 
as expected. Furthermore, for pQIRYHQCYFNPISCF, the measured m/z of 950.924 
matched the theoretical m/z for the doubly-protonated peptide (Fig. 8B and Table 3). 
There were also significantly less intense peaks matching the singly- and triply-charged 
states. Similarly, the most abundant m/z peak for SYWKQCAFNAVSCFamide (m/z 
825.866) matched the theoretical m/z for the doubly-protonated peptide (Fig. 8D and 
Table 3). A dramatically less intense peak matching the triply-charged state mass for 
pQIRYHQCYFNPISCF was also observed.  
Table 3. Target Peptide Sequences, Masses, and Single, Doubly, and Triply Charged 
State Mass-to-Charge (m/z) Ratios 
Peptide Name 
Sequence (possible 




















pQIRYHQCYFNPISCF  1898.8234 1899.831 950.419 633.948 
 
*SYWKQCAFNAVSCFamide 1649.712 1650.719 825.863 550.911 
AST-C reduced 
pQIRYHQCYFNPISCF  1900.838 1901.845 951.426 634.620 
 
*SYWKQCAFNAVSCFamide 1651.727 1652.734 826.871 551.583 
a 











Fig. 8. Chromatograms and MS spectra for pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide. (A) Chromatogram for pQIRYHQCYFNPISCF, 





ion with m/z 950.924 was most abundant. (C) Chromatogram for 





ion with m/z 825.866 was most 
abundant.  
 
To determine how the disulfide bond influenced chromatographic retention and 
mass spectral properties, the reduced forms of pQIRYHQCYFNPISCF and 
SYWKQCAFNAVSCFamide were generated. For both peptides, the reduced form eluted 
later than the oxidized, disulfide-bonded peptide (Fig. 9A). The increase in retention for 
the reduced peptide may result from the peptide being able to assume a more linear form 
with stronger interactions with the stationary phase. The MS spectra showed the expected 
mass shifts from the addition of two hydrogen atoms; the [M+2H]
2+
 was the most 
abundant charge state for both reduced peptides (data not shown).  
Although these MS peaks matched theoretical m/z values, peptide masses are 
insufficient to confirm amino acid sequences. Therefore, MS/MS data are needed to 
verify peptide identity. Using the known total peptide mass, differences between MS/MS 











A     pQIRYHQCYFNPISCF 
C  SYWKQCAFNAVSCFamide 
 
D  SYWKQCAFNAVSCFamide 
 

































revealed where that amino acid was in the overall sequence. By compiling these fragment 
m/z values, the total sequences for both peptides were confirmed. 
MS/MS data were collected in order to characterize and confirm the sequences of 
oxidized SYWKQCAFNAVSCFamide (Fig. 9B) and reduced 
SYWKQCAFNAVSCFamide (Fig. 9C) forms. For MS/MS analysis, the abundant 
[M+2H]
2+
 precursor ion was selected by the quadrupole mass filter and was dissociated 







Fig. 9. LC-MS/MS characterization of SYWKQCAFNAVSCFamide 
standard and SYWKQCAFNAVSCFamide. (A) SYWKQCAFNAVSCFamide 
eluted at 18.39 min and SYWKQCAFNAVSCFamide eluted slightly later at 
19.24 min. (B) MS/MS spectrum collected for sequence confirmation. Peptide 
structure shown at top. Ions and residues shown in red were detected by MS/MS 
analysis. SYWKQCAFNAVSCFamide was mostly fragmented at sites outside the 
disulfide bond. (C) SYWKQCAFNAVSCFamide (reduced) allowed for 







type ions, which include the C-terminus of the peptide, and b-type ions, which include 
the N-terminus. Low mass immonium ions, which are characteristic of different amino 
acids present in the sequence, appear at low mass and are identified by the one-letter 
amino acid codes.  
The oxidized SYWKQCAFNAVSCFamide peptide was mostly fragmented at 
sites outside the disulfide bond and very little fragmentation was observed at sites 
between the cysteine residues (Fig. 9B). However, the reduced form of this peptide was 
highly fragmented at many sites and the mass spectrum showed evidence of most of the 
amino acid sequence. This suggested that the disulfide bond provided structural stability 
that prevented fragmentation. In the oxidized peptide, the breakage of a bond between the 
two cysteine residues would not produce fragmentation because the unbroken disulfide 
bond would keep the peptide intact. Similarly, breaking the disulfide bond without 
breaking a peptide bond would not produce any fragmentation. That is, in order for 
SYWKQCAFNAVSCFamide to fragment at a site between the cysteine residues, both 
the disulfide bond and a peptide bond must be broken. Therefore, few ions formed by 
fragmentation at sites between the cysteine residues were detected. Reducing the 
disulfide bond facilitated internal fragmentation, as supported by MS/MS data (Fig. 9C). 
MS/MS data for pQIRYHQCYFNPISCF also showed high characteristic fragmentation 
outside the disulfide-bonded cysteine residues (data not shown).  
 
3.2 Detection limit assessment in sample matrix 
To evaluate detection limits, an eyestalk extract was used as a sample matrix and 
was spiked with increasing concentrations of target peptides to mimic the behavior of a 
biological tissue extract. To prepare the extract, an eyestalk ganglion was extracted into 
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an acidified methanol solvent. The tissue was heated at 100°C to denature enzymes that 
would attack the target peptides and was then homogenized and sonicated to release 
biological material into the extraction solvent (Stemmler et al., 2013). The sample was 
centrifuged to remove insoluble material and the supernatant was filtered to further 
eliminate insoluble contaminants. The diluted solution showed no 
pQIRYHQCYFNPISCF peptide signals.  
Each peptide-spiked tissue extract was analyzed by LC-MS, chromatographic 
peaks were integrated, and peak area was plotted as a function of peptide concentration 
(Fig. 10). pQIRYHQCYFNPISCF showed higher signal-to-concentration linearity (R
2 
= 
0.996) than SYWKQCAFNAVSCFamide (R
2 
= 0.802), but both relationships were fairly 
linear. Based upon the 0.5 µL injection volume, the minimum amount of peptide detected 
was 25 fmol for pQIRYHQCYFNPISCF and 5.0 fmol for SYWKQCAFNAVSCFamide. 
This provided reassurance that when quantifying peptide levels, a linear calibration curve 
could be used to reliably determine the concentration of peptide present in a sample with 
a given target peptide signal intensity.  
For a given change in peptide concentration, signal intensity increased more for 
pQIRYHQCYFNPISCF than for SYWKQCAFNAVSCFamide. This is indicated by the 
greater slope for the pQIRYHQCYFNPISCF regression line and suggested that this 
peptide is more easily ionized and detected. Arg
3
 is the most basic amino acid and is 
contained in pQIRYHQCYFNPISCF, thereby making its affinity for protonation higher 
than that of SYWKQCAFNAVSCFamide. In contrast, SYWKQCAFNAVSCFamide 
only has two probable protonation sites at the N-terminus and the less basic Lys
4






Fig. 10. Peak area vs. peptide concentration for 
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide in sample 
matrix. Both relationships were linear (R
2 
< 0.99 for 
pQIRYHQCYFNPISCF and R
2 
= 0.80 for SYWKQCAFNAVSCFamide. 
Minimum amount of peptide detected was 25 fmol 
pQIRYHQCYFNPISCF and 5.0 fmol SYWKQCAFNAVSCFamide. 
 
3.3 Peptide detection in PO and eyestalk 
To determine if target peptides could be detected in a tissue extract, PO and 
eyestalk tissues from H. americanus were analyzed by LC-MS. pQIRYHQCYFNPISCF 
was detectable in a single PO extract. The chromatogram for the most abundant charge 
state of pQIRYHQCYFNPISCF showed an intense signal at 6.905 min (Fig. 11A). At 
this retention time, MS data shows an abundant doubly-charged ion with m/z 950.419 and 
a low-intensity singly-charged ion with m/z 1899.831 (Fig. 11B). MS/MS data (not 
shown) confirmed the identity of pQIRYHQCYFNPISCF. Neither MS nor MS/MS data 
showed evidence of the reduced form in this biological sample. Other abundant masses 
corresponded to peptides common to crustaceans including orcokinins, SIFamide, 



























2011). Confirming the detection of pQIRYHQCYFNPISCF in a single PO extract gave 
confidence that quantification of very small peptide amounts was feasible; however, this 
analysis also highlighted challenges associated with the analysis.  
 
Fig. 11. pQIRYHQCYFNPISCF detection in PO. (A) Total ion 
chromatogram (green) and extracted ion chromatogram (red) for expected 
most abundant m/z. Scaled to largest peak in each chromatogram. (B) MS 
data at peptide retention time showed an abundant doubly-charged ion 
with m/z 950.419 and an additional low-intensity peak for a singly-
charged ion with m/z 1899.831. Contaminant peak shown has been seen in 
previous work and is known to coelute with pQIRYHQCYFNPISCF (E. 
Stemmler, unpublished data).  
 
Some of these challenges included high levels of sample contamination (see total 
ion chromatogram in Fig. 11A showing many non-peptide peaks), most significantly 
phospholipids that can interfere with analysis. Variable peptide signal intensities may be 
associated with phospholipid contamination, dissection techniques, time of dissection, 
homogenization, or adsorptive losses. Specifically, when analyzing PO and eyestalk 





There appeared to be no substantial signal intensity discrepancies between eyestalk 
extracts prepared by manual or motorized tissue homogenization or between dissections 
times of 10 min (short) and 20 min (long). Previous research has shown evidence that 
circadian rhythm in crayfish controls peptide manufacturing. Crustacean hyperglycemic 
hormone (CHH) levels are especially influenced by these patterns (Fanjul-Moles et al., 
2010). Therefore, it is possible that neuropeptide expression patterns in H. americanus 
vary throughout the day. In addition, physiological conditions also affect peptide 
manufacturing (Strauss and Dircksen, 2010; Hou et al., 2012). In future experiments, 
these factors should be controlled for by extracting tissues at roughly the same times of 
day.  
3.4 Delipidation 
Phospholipids are known to hinder peptide ESI protonation, thereby interfering 
with peptide detection in biological samples (Van Eeckhaut et al., 2009). Since 
chloroform effectively dissolves large phospholipids and not peptides, it has served as a 
successful medium for removing lipids from aqueous tissue extracts (Folch et al., 1957). 
To determine if a micro liquid-liquid extraction with chloroform could be used to extract 
phospholipids from tissue extracts, a tissue extract was analyzed before and after 
chloroform extraction. The chloroform-methanol extraction successfully extracted lipids 
from neuropeptide material. Phospholipid signal intensity was much less when the 
chloroform extraction was performed, suggesting successful delipidation. However, there 
was essentially no difference in crustacean peptide signal intensity between samples. 
Furthermore, white precipitate formed upon extraction, raising concerns about sample 
loss. Therefore, this approach was not pursued as a useful method to improve peptide 
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recovery or detection. Whereas this technique involves liquid-liquid extraction, another 
student tested solid phase extraction using C18 spin columns for delipidation. The 
hydrophobic phospholipids should partition into the C18 stationary phase to separate 
components from other peptides. This may be a more effective alternative that will be 
explored in future experiments.  
3.5 Internal standard selection and characterization 







]vasopressin, and oxytocin were selected as 
potential internal standards. These internal standard sequences and masses are presented 
in Table 4, with basic residues and likely protonation sites shown in bold. These are non-
crustacean neuropeptides not found in H. americanus. Due to the disulfide bond linking 
the cysteine residues in each internal standard, these peptides were expected to behave 
similarly to the target peptides. That is, any loss of pQIRYHQCYFNPISCF or 
SYWKQCAFNAVSCFamide due to heat treatment, loss to tubes or pipet tips during 
transfers, or losses when extracting or filtering, for instance, was also expected to affect 
the selected internal standards. The amidated C-terminus of each internal standard 







]vasopressin, and oxytocin were 
expected to serve as appropriate recovery references for quantification.  
In the initial steps of quantification method development, the internal standards 
were characterized by LC-MS/MS as individual components and as mixtures of multiple 
standards. For all four internal standards, MS data showed that the doubly-charged ion 







]vasopressin were likely protonated at Arg
8
, the most 
basic amino acid, and [Lys
8
]vasopressin at the Lys
8
, another highly basic amino acid. The 
most likely second protonation site on oxytocin is Pro
7
 (Moret and Zebende, 2007). 
When the four peptides were mixed together at equal concentrations of 10 µM and 
analyzed by LC-MS, they were chromatographically separated, as shown in Fig. 12.  
 
Fig. 12. EIC overlays for internal standard mixtures. All standards 
were at equal concentrations of 10 µM. The peak heights were scaled to 
the same value to show chromatographic peak shapes.  
Table 4. Internal Standard Sequences, Masses, and Single, Doubly, and Triply Charged 
State Mass-to-Charge (m/z) Ratios 
Peptide Name 
Sequence (possible 






























*CYFQNCPRGamide 1083.439 1084.446 542.727 362.154 
oxytocin 
*CYIQNCPLGamide 1006.438 1007.445 504.226 336.487 
a 












Because AST-C concentrations in tissue extracts may vary significantly, a multi-
level internal standard calibration approach was defined. This requires mixtures of the 
four internal standards that each differ by an order of magnitude. In mixtures containing 
the highest concentrations, we expected that the more abundant peaks would be 
overloaded and unsymmetrical, and needed to ensure that these peaks did not interfere 
with lower concentration standards. In evaluating the appropriate internal standard 
concentration levels, mixtures with symmetric peptide chromatographic peaks for the 
peptide being used as the appropriate internal standard would be most reliable for 
quantification. In addition, target peptide chromatographic peak areas should be within 
the range of that of the internal standard peak areas. Having some internal standards elute 
before and some after the target peptides would also be ideal (Hou et al., 2012).  
To evaluate how concentration changes impacted peak shapes, four internal 
standard mixtures were prepared and analyzed by LC-MS (Fig. 13). Mixtures #1 and #2 
(Table 2) showed undesirable asymmetric chromatographic peaks for standards in high 
concentrations caused by column overloading. Mixture #3 showed symmetric 





]vasopressin elute at similar times, a 
combination of one of these two peptides, [Arg
8
]vasotocin, and oxytocin would offer 





Fig. 13. Chromatogram overlays for internal standard mixtures. The 
peak heights were scaled to the same value to show chromatographic peak 







]vasopressin, and (4) oxytocin. Adapted from a figure provided 
by E. Stemmler.  
 
3.6 Internal standard mixtures with target peptides showed evidence of analyte loss 
The target peptides, pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide, 
















 M oxytocin with 10
-5
 M of each target peptide, the target peptide signals were 




]vasotocin (10 times more concentrated), 
suggesting that the target peptides had a higher nanoESI ionization efficiency. The 
mobile phase gradient was optimized to minimize chromatographic peak overlap between 
the target peptides and internal standards. Using the optimized gradient, [Arg
8
]vasotocin 
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]vasopressin, and oxytocin, 
respectively. The target peptides eluted later in the chromatogram than the internal 
standards (data not shown).  
To investigate relative signal intensities as a function of concentration, several 
standard mixtures of a single internal standard, [Arg
8
]vasotocin, mixed with 
SYWKQCAFNAVSCFamide and pQIRYHQCYFNPISCF were characterized. However, 
there were inconsistencies in signal strengths for the target peptides. For example, a 10 
µM mixture of the target peptides and [Arg
8
]vasotocin showed saturated signals for the 
two target peptides at this high concentration (Fig. 14A), while a 10-fold dilution of this 
solution showed SYWKQCAFNAVSCFamide and pQIRYHQCYFNPISCF peaks that 
were approximately 40 and 500 times lower in response, respectively (Fig. 14B). 
Multiple replicates showed that upon an additional 10-fold dilution, the peptides were 
undetectable. These decreases in signal strength are far greater than the approximate 10-







Fig. 14. Target peptide signal losses upon sample dilution. (A) A 10 
µM solution yields saturated signals for the two target peptides. (B) Upon 
10-fold dilution of this solution, SYWKQCAFNAVSCFamide and 
pQIRYHQCYFNPISCF peaks were approximately 40 and 500 times 
lower in response, respectively.  
 
All of these disproportionate losses in relative signal strength suggested possible 
peptide adsorption to the sample vial walls that was dependent on relative concentrations. 
During initial work directed at characterizing the target peptides, greater-than-expected 
losses of AST-C peptide signals were found following serial dilutions. For example, 
when pQIRYHQCYFNPISCF serial dilutions were prepared in standard plastic tubes 
before being transferred to polypropylene vials for analysis, chromatographic peaks 
decreased more dramatically than the expected dilution factor. In contrast, when dilutions 
were prepared directly in polypropylene LC-MS vials, the expected change in signal 












A 10 µM  
B 1 µM  
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10 µM pQIRYHQCYFNPISCF in water and 0.5 µL of each was injected for analysis. 
Therefore, the signals for the target peptide were expected to be equivalent. Contrary to 
expectations, the chromatographic peak area for the sample prepared in the 
polypropylene vial was about two orders of magnitude larger than that for the solution 
prepared in standard plastic (220 x 10
5
 compared to 5 x 10
5
). In contrast, 
SYWKQCAFNAVSCFamide did not show similar patterns and there did not seem to be 
any substantial sample loss in these early experiments.  
 
Fig. 15. pQIRYHQCYFNPISCF sample loss. In this chromatogram 
overlay, 10 µM of solution prepared directly in polypropylene vials 
showed a much more intense signal (peak area 2 x 107) than for a solution 
of equivalent peptide concentration and injection volume prepared from a 
serial dilution in standard plastic tubes (peak area 5 x 105).  
In this early work, it was hypothesized that this signal loss was due to the affinity 
of the peptide to the walls of the standard plastic vials. Previous studies have shown that 
some peptides exhibit this behavior when stored in glass or standard plastic, which can 
contribute to significant sample loss (Kraut et al., 2009). After observing such loss, all 
samples were prepared in low-retention plastic tubes to prevent peptide adsorption in 
standard plastic tubes. Furthermore, 25% acetonitrile (ACN) was included in dilution 
solvents to help prevent adsorptive losses. Such use of organic solvent has been shown to 
improve signal-to-concentration linearity (Warwood et al., 2013). In the present study, 
Diluted in polypropylene 
Diluted in standard plastic 
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we expected that diluting samples in organic solvent in low-retention tubes would prevent 
peptide loss. However, analyte loss was still observed in subsequent experiments. This 
led to a more detailed investigation of the causes of peptide signal loss.  
3.7 Factors that may lead to analyte loss 
Before proceeding with the development of a method for peptide quantification, 
the sources of these signal losses needed to be identified. Due to repeated evidence of 
sample loss, the focus of this study shifted to addressing factors leading to analyte loss. 
Factors that have been shown to negatively impact signal recovery include adsorptive 
losses to analysis vial walls, pipette tips, and various parts within the LC-MS instrument 
due to hydrophobic, hydrophilic, or electrostatic interactions between the analyte and 
adsorptive surface. Previous work has shown that at low concentrations, signal strength is 
highly compromised because a substantial proportion of peptide present is adsorbed. This 
can make the analyte barely detectable. At high concentrations, sample loss to adsorption 
is less drastic relative to the amount of peptide in solution (Maes et al., 2014). Since such 
research suggested that vial material could compromise signal recovery, a more rigorous 
systematic analysis of potential causes of these losses was performed in the present study.  
3.8 Analyte loss to sample vials 
To test whether loss was affected by analysis vial material, solutions of 
[Arg
8
]vasotocin and the target peptides at equal concentrations of 10
-6
 M were diluted 
directly into either a low-retention polypropylene or glass vial. Chromatography showed 
a dramatic reduction in pQIRYHQCYFNPISCF signal intensity when using 
polypropylene (Fig. 16A) compared to glass (Fig. 16B). These results were consistent 
with a previous study finding that glass is preferred for storing hydrophobic peptides 
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(Van Midwood et al. 2007). pQIRYHQCYFNPISCF contains hydrophobic residues (one 
Pro, two Ile, and two Phe residues) and elutes at a late retention time, suggesting that this 
is a particularly hydrophobic peptide. Ultimately, the results of the present study 
suggested that vial material affected signal recovery and that glass was preferred over 
polypropylene for detecting hydrophobic peptides. 
 
Fig. 16. Evidence of SYWKQCAFNAVSCFamide reduction and 
pQIRYHQCYFNPISCF sample loss. (A) Low intensity signal for 
pQIRYHQCYFNPISCF when prepared in plastic. (B) 
pQIRYHQCYFNPISCF signal recovered when prepared in glass. Scaled 
to largest peak in each chromatogram.  
 
However, hydrophobicity alone is not sufficient to explain why the 



















(four internal standards and both target peptides) and least intense for the three-peptide 
mixture ([Arg
8
]vasotocin and both target peptides). In the six-peptide mixture, 
[Arg
8
]vasotocin was 10 times more concentrated than the target peptides (10
-5
 M), 
making it possible that this internal standard occupied most of the adsorptive sites on the 
polypropylene vial walls. In contrast, for the three-peptide mixture, [Arg
8
]vasotocin and 
the target peptides were at equal concentrations of 10
-5
 M. Here, as explained by Maes et 
al., it is likely that the most hydrophobic peptide was unhindered by a more concentrated 
species from binding to the adsorptive sites. This suggests that adsorption may be 
concentration-dependent.  
3.9 Prewashing analysis vials for signal recovery 
In addition to vial material, contaminants or coatings inside the vials could have 
caused adsorptive losses. To test this, prewashing polypropylene and glass vials with 
water, 25% ACN, and isopropanol was explored as a way to eliminate unwanted 
contaminants. Across replicate experiments, prewashing polypropylene vials with 
isopropanol showed greater pQIRYHQCYFNPISCF signal recovery than any other 
treatment (Fig. 17). That is, the mean prewash-to-no prewash ratios were significantly 
higher for the isopropanol-washed polypropylene treatment than all other conditions 
(ANOVA, N = 2). These results suggested that prewashing polypropylene vials with 
isopropanol successfully conserved hydrophobic peptide signal intensity, possibly 
because isopropanol washed away any hydrophobic contaminants on the polypropylene 




Fig. 17. Prewash-to-no prewash ratios of pQIRYHQCYFNPISCF 
peak areas. 1 µM pQIRYHQCYFNPISCF analyzed in (A) polypropylene 
and (B) glass vials prewashed in H2O, 25% ACN, and isopropanol. 
Prewash-to-no prewash ratio for isopropanol-washed polypropylene was 
significantly higher than the remaining treatments (ANOVA, N = 2). 
There were no significant differences between prewash-to-no prewash 
ratios for the other conditions (ANOVA, N = 2 for each condition).  
Peptide standard solutions diluted using isopropanol-washed low-retention tubes 
and pipette tips did not have any apparent effect on pQIRYHQCYFNPISCF signal 
recovery. Sonication of samples before analysis also did not increase signal intensity 
(data not shown). Isopropanol-washed polypropylene vials were used for all subsequent 
experiments.  
3.10 No initial evidence for sample loss within the instrument when varying 
injection volumes at constant peptide concentration  
To test whether loss occurred within the instrument during analysis, injection 
volume was varied at constant peptide concentration. Loss at this point in the analysis 
could result from adsorptive losses to surfaces including, but not limited to, the injection 
needle, column, tubing, and mass spectrometer. Especially basic peptides can stick to 
metal surfaces while hydrophobic peptides tend to stick to plastic surfaces. 
pQIRYHQCYFNPISCF is particularly hydrophobic and contains basic residues, making 
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it prone to such losses. Any instrument loss would compromise the signal-to-injection 
linearity, especially at low concentrations where adsorptive losses are most evident (Maes 
et al., 2014).  
A preliminary experiment showed that increasing injection volumes of the same 
peptide sample yielded pQIRYHQCYFNPISCF signals that increased linearly. Multiple 
injections of 1 µM pQIRYHQCYFNPISCF analyzed in isopropanol-washed 
polypropylene vials showed that the relationship between peak area and the amount of 
peptide injected was strongly linear, suggesting that sample loss in the instrument during 
analysis was negligible (Fig. 18). If there were sample loss here, signals for small 
injection volumes would be compromised. Greater injection volumes would be less 
affected because the amount of sample lost would be negligible compared to the amount 
of peptide injected. This would decrease the signal-to-injection volume linearity. 
However, these results showed that sample loss within the instrument did not affect 




Fig. 18. pQIRYHQCYFNPISCF peak area vs. volume of 1 µM peptide 
injected. The relationship between pQIRYHQCYFNPISCF peak area and 
injection volume was strongly linear (R2 > 0.99).  
3.11 More in-depth investigation of concentration-dependent losses 
In addition to the internal standard mixture analyses discussed in Sections 3.5 and 
3.6, other preliminary data showed evidence of potential concentration-dependent signal 
loss. Signal intensity for a given molar amount of peptide injected was not expected to 
change between samples regardless of initial concentration. That is, signal intensity was 
expected to be the same when injecting 0.1 µL of 1 µM peptide and 1.0 µL of 0.1 µM 
peptide because 100 fmol of peptide was injected in both conditions. Contrary to this 
prediction, pQIRYHQCYFNPISCF was detectable from a 0.1 µL injection of 1 µM 
peptide (Fig. 19A), but was nearly undetectable from a 1.0 µL injection of 0.1 µM 
peptide (Fig. 19B). Since the same amount of peptide should have been injected in both 
conditions, these results suggested signal loss was concentration-dependent. This led to 
further exploration of the potential causes for this observed signal loss by analyzing 
additional peptides that differed in size and hydrophobicity.  
y = 22.99x - 1.30 


























Fig. 19. EICs for 100 fmol pQIRYHQCYFNPISCF injections. (A) 0.1 
µL injection of 1 µM peptide and (B) 1.0 µL injection of 0.1 µM peptide 
were injected. pQIRYHQCYFNPISCF was detected from the 1 µM 
solution, but not the 0.1 µM solution.  
 
3.12 Signal loss dependence on peptide size and hydrophobicity 
Mixtures of seven peptides varying in size and hydrophobicity were characterized 
to determine whether signal loss was dependent on concentration or peptide-specific 
properties (Table 5 and Fig. 20). These peptides were selected based on availability, 
retention time, and chromatographic resolution. RTVGGFA, RAAFGFA, and RTVFGFA 
were relatively small in size and contained between three and five hydrophobic residues. 
AST-B and AFDEIDRSGFGFA were slightly larger in size and contained five and six 
hydrophobic residues, respectively. CLDH was very large and hydrophobic compared to 
the other peptides, including pQIRYHQCYFNPISCF. In conjunction with the proportion 
of hydrophobic residues, retention time was used as the primary determinant of peptide 






because they interacted most favorably with the hydrophobic stationary phase. 
pQIRYHQCYFNPISCF appeared to be most difficult to detect (smallest peak area) and 
eluted latest.  





(hydrophobic residues in 





9.8 RTVGGFA  706.3761 354.1954 
13.8 RAAFGFA  738.3812 370.1979 
14.8 TNWNKFQGSWamide AST-B 1265.5940 633.8044 
15.6 RTVFGFA  796.4231 399.2188 
17.3 AFDEIDRSGFGFA  1430.6470 716.3306 
20.1 GLDLGLGRGFSGSQAAKH
LMGLAAANFAGGPamide 
CLDH 2939.5190 735.8870 






Fig. 20. Merged EIC of seven peptides in sample loss analysis. 
Chromatogram shows retention times and relative signal intensity of the 
seven peptides.  
 
A mixture of these seven peptides was tested for signal loss at different 
concentrations and injection volumes. Concentration was varied to reveal whether any 
observed signal loss could be attributed to concentration-dependent sample loss. Injection 
































































instrument. Detected peak areas were plotted as a function of the amount of peptide 
injected (Fig. 21); points originating from solutions of different concentrations were 
overlayed to determine if the same amount of injected peptide yielded the same peak 
area.  
The relationship between peak area and the amount of peptide injected was highly 
linear for the small peptides: RTVGGFA (Fig. 21A, R
2
 = 0.99), RAAFGFA (Fig. 21B, R
2
 
= 0.98) and RTVFGFA (R
2
 = 0.99) for all three solution concentrations (0.4, 0.7 and 1.0 
µM). Data for AST-B was also fairly linear (R
2
 = 0.91). However, this pattern was not 
observed for the later eluting peptides, including CLDH (Fig. 21C) and 
pQIRYHQCYFNPISCF (Fig. 21D), which did not show evidence of strong signal-to-
injection linearity.  
The signal-to-injection nonlinearity for the two most hydrophobic peptides 
provided strong evidence for concentration-dependent sample losses during LC-MS 
analysis, with more analyte being lost when smaller injection volumes were used. In 
addition to the curvature observed as a function of injection volume, CLDH and 
pQIRYHQCYFNPISCF behaved differently at each mixture concentration, as shown by 
the lower peak areas for equivalent amounts of peptide injected from solutions of 
different concentration. This suggested that concentration-dependent sample loss could 
also have occurred when the solutions were diluted. For pQIRYHQCYFNPISCF, the 
signals were generally very weak or undetectable at 0.4 µM. Notably, CLDH and 
pQIRYHQCYFNPISCF are most impacted by the observed peptide loss. These peptides 






Fig. 21. Peak area vs. amount of peptide injected for (A) RTVGGFA, (B) 
RAAFGFA, (C) CLDH, and (D) pQIRYHQCYFNPISCF. This relationship 
was highly linear for this RTVGGFA (R2 = 0.99) and RAAFGFA (R
2
 = 0.98). 
However, these curves were fit to second order polynomials for CLDH and 
pQIRYHQCYFNPISCF. Injection volumes varied from 0.01–1.3 µL of seven-
peptide mixtures varying from 0.4–1 µM in concentration. 
pQIRYHQCYFNPISCF was not detected at 0.4 µM. 
We also compared these most recent data with earlier experiments that showed a 
linear relationship between pQIRYHQCYFNPISCF signal intensity and injection volume 
(Fig. 18). This discrepancy could have been influenced by factors such as samples run 
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peptide detection. Nonetheless, this more extensive experiment testing multiple peptides 
at various concentrations and injection volumes showed convincing evidence of 
instrument loss for more hydrophobic peptides, which led to further investigation of 
techniques to reduce such losses.  
3.13 Signal recovery in solution with PEG 
Diluting peptide samples in polyethylene glycol (PEG, 0.001%) has previously 
been shown to increase signal recovery of various peptides by reducing adsorptive losses 
(Stejskal et al., 2013). This sample treatment was explored for solutions containing 
pQIRYHQCYFNPISCF. Consistent with the findings of Stejskal and colleagues, PEG 
successfully increased signal recovery for the peptide of interest, pQIRYHQCYFNPISCF 
(Fig. 22). pQIRYHQCYFNPISCF absolute peak areas for samples diluted in water were 
generally weak compared to those diluted in 0.001% PEG in water (Fig. 22A). There was 
a much greater difference in absolute peak area for the solutions at higher concentration 
(0.7 µM); however, the relative increase in peak area was much greater for solutions at 
the lower concentration (0.4 µM) (Fig. 22B). This suggested that PEG had a greater 
effect on signal recovery at lower concentrations. This is consistent with findings in both 
the present study and previous research showing that adsorptive losses most significantly 
affect solutions at low concentrations, whereas solutions at higher concentrations are less 
impacted.  
In contrast, dilution in 0.001% PEG generally showed moderately decreased 
signal recovery for the remaining peptides at concentrations of 0.1, 0.4, and 0.7 µM, with 
the exceptions of AST-B at 0.4 µM and RTVFGFA at 0.1 µM (data not shown). 
Therefore, PEG may have interfered with the detection of these smaller, more hydrophilic 
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peptides while enhancing signal recovery of pQIRYHQCYFNPISCF. Nonetheless, this 
served as a potential technique for analyzing hydrophobic peptides at low concentrations.  
 
 
Fig. 22. Peak area vs. amount of pQIRYHQCYFNPISCF injected 
with and without 0.001% PEG in solution. (A) Adding 0.001% PEG 
increased absolute pQIRYHQCYFNPISCF peak areas most for samples at 
higher concentrations. (B) PEG-to-no PEG signal ratios were highest at 












































Although PEG successfully increased signal recovery for hydrophobic peptides, 
biological samples contain a broad range of peptides that vary greatly in size, 
hydrophobicity, and other properties. Therefore, optimizing detection of one category of 
peptide would prevent accurate quantification of other types of peptides. Moreover, 
peptides are found at very low concentrations in biological samples and their detection 
requires high sensitivity. However, results showed that signal recovery is most highly 
compromised for low analyte concentrations. Ultimately, the present study demonstrated 
that in order to minimize analyte loss, factors such as adsorptive losses during sample 
preparation and analysis that are especially problematic for hydrophobic peptides must be 
addressed.  
FUTURE WORK 
The source of peptide signal loss and techniques for signal recovery must be 
optimized in order to allow for successful peptide quantification in biological samples. 
Overall, the results of the present study show that there are likely multiple sources of 
sample loss, including adsorptive losses to vials and LC-MS components that most 
drastically affect hydrophobic peptides at low concentrations.  
In the future, PEG should be tested as a prewash for analysis vials that would coat 
adsorptive sites on the vial walls without interfering with peptides in solution. More 
extensive experiments should be performed to analyze the target peptides across broader 
concentration ranges and injection volumes in continued effort to identify the conditions 
under which signals are most highly compromised. This will also help determine whether 
signal loss is primarily a function of peptide concentration, size, hydrophobicity, or other 
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factors such as temperature, which can particularly affect the detection of hydrophobic 
peptides (Maes et al., 2014).  
After developing a method for optimal sample preparation, attention can be 
redirected at the goal of peptide quantification in biological samples by a multipoint 
internal standard mixture. This would involve determining the amount of internal 
standard that must be added at the beginning of the extraction process in order to recover 
the amounts that give the desired chromatographic signal intensity. This could be done 
experimentally by adding known concentrations of the internal standards to the extraction 
solvent before tissue removal from the animal. Following peptide extraction, the sample 
could be analyzed to determine the amount of internal standard and analyte recovered. 
Since the target peptides are found in very low concentrations in the eyestalk and PO, the 
number of tissues that might need to be pooled to detect the desired amount of peptide 
also must be determined experimentally. By pooling the desired number of tissues and 
adding the appropriate amount of internal standard, it would be possible to quantify the 
amount of target peptide in a single tissue.  
Other future directions of this study could include identifying other modified and 
unmodified forms of pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide. This 
information could be coupled with biological analyses to determine which forms are 
bioactive. Currently, there is little known information about how post-translational 
modifications contribute to bioactivity. This research will contribute to efforts to clarify 
the role of post-translational modifications in bioactivity and to identify differences 
between the functions of the structurally similar AST-C peptides. Above all, this 
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knowledge will help explain neuropeptide interactions and their influence on behavior in 




APPENDIX I: COLOR FIGURES IN GRAYSCALE 
 
Fig. 2B. Disulfide bond formation between two cysteine residues.  
 
 














Fig. 7. Peptide quantification by internal standard. 
 
 




Fig. 11. pQIRYHQCYFNPISCF detection in PO. (A) Total ion chromatogram 
and extracted ion chromatogram for expected most abundant m/z. Scaled to 
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